{
    "id": 25531,
    "fullName": "RPS6KA5 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "RPS6KA5 positive indicates the presence of the RPS6KA5 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 9252,
        "geneSymbol": "RPS6KA5",
        "terms": [
            "RPS6KA5",
            "MSK1",
            "MSPK1",
            "RLPK"
        ]
    },
    "variant": "positive",
    "createDate": "10/18/2016",
    "updateDate": "11/19/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8937,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, inhibition of RPS6KA5 via shRNA combined with DS-7423 in glioma cell line xenograft models resulted in the greatest sensitivity compared to either inhibitory mechanism alone, demonstrating increased survival (PMID: 27196759).",
            "molecularProfile": {
                "id": 26537,
                "profileName": "RPS6KA5 positive"
            },
            "therapy": {
                "id": 722,
                "therapyName": "DS-7423",
                "synonyms": null
            },
            "indication": {
                "id": 60108,
                "name": "brain glioma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 6791,
                    "pubMedId": 27196759,
                    "title": "MSK1-Mediated \u03b2-Catenin Phosphorylation Confers Resistance to PI3K/mTOR Inhibitors in Glioblastoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27196759"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26537,
            "profileName": "RPS6KA5 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}